|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
Plus ça change, plus c'est la même chose
Three months into the third year of the brave new millennium and I'm wondering if our fragile world is any closer to delivering the nirvana promised by exciting scientific discoveries at the turn of the decade. Is it simply the case that the more things change the more they seem the same?
What happens in life science media may be a useful paradigm for the sector as a whole. For example, in the run-up to Y2K B2B magazines, websites and events boomed on the back of 'new age' high-tech industries in electronics, IT, pharma and biotech. So much money pumped in by not-so-savvy investors looking for a piece of the action created a bubble that was ripe to burst.
A downturn in advertising revenues was the first sign of difficult times ahead - it wasn't long before media groups began downsizing, with staff lay-offs and distress sales. Recession in the wider economy followed, with 9/11 taking a lot of the blame.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
